A comparative study of efficacy and safety of azithromycin and ofloxacin in uncomplicated typhoid fever: A randomised, open labelled study

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 10, 2012, Pages 1736-1739

  Chandey, Manish ^a   Multani, A S ^a  

^a SRI GURU RAM DAS INSTITUTE OF MEDICAL SCIENCES AND RESEARCH   (India)

Author keywords

Azithromycin; Ofloxacin; Typhoid fever

Indexed keywords

AZITHROMYCIN; OFLOXACIN;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; INDIA; MALE; NAUSEA AND VOMITING; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TYPHOID FEVER;

EID: 84871867406     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2012/4702.2631     Document Type: Article

References (11)

1. M. Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, et al. The Influence of Reduced Susceptibility to Fluoroquinolones in Salmonella enterica Serovar Typhi on the Clinical Response to Ofloxacin Therapy. PLoS Neglected Tropical Diseases. 2011; 5(6): e1163.
2. Lesser CF, Miller SI. Salmonellosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL editor(s). Harrison'sPrinciples of Internal Medicine. 15th Edition. Vol. 1, New York:McGraw-Hill, 2001:971-73.
3. Effa EE, Bukirwa H. Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006083. DOI: 10.1002/14651858. CD006083.pub2.
4. Bethell DB, Day NPJ, Nguyen MD, et al. (1996) Pharmacokinetics of oral and intravenous ofloxacin in multidrug-resistant typhoid fever. Antimicrob Agents Chemother. 1996; 40: 2167-72.
5. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, et al. Antimicrobial drug resistance of Salmonella enterica serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother. 2007; 51: 4315-23.
6. Crump JA, Kretsinger K, Gay K, Hoekstra RM, Vugia DJ, et al. Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study. Antimicrob Agents Chemother. 2008; 52: 1278-84.
7. Joshi S, Amarnath SK. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2007;101(3):308-10.
8. Chambers HF. Chloramphenicol, tetracyclines, macrolides, clindamycin, and streptogramins. In: Katzung BG editor(s). Basic and Clinical Pharmacology. 9th Edition. Boston: McGraw Hill,2004:754-63.
9. Butler T, Frenck RW, Johnson RB, Khakhria R. In vitro effects of azithromycin on Salmonella typhi: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula. Journal of Antimicrobial Chemotherapy. 2001;47(4):455-8.
10. Rai S, Jain S, Prasad KN, Ghoshal U, Dhole TN. Rationale of azithromycin prescribing practices for enteric fever in India. Indian J Med Microbiol. 2012;30:30-33.
11. Girgis N, Butler T, Frenck RW, Sultan Y, Brown FM, Tribble D, et al. Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother. 1999;43:1441-44.